Targeting Orphan G Protein-Coupled Receptor 17 with T0 Ligand Impairs Glioblastoma Growth

SIMPLE SUMMARY: Glioblastoma multiforme (GBM), or glioblastoma chemotherapy, has one of the poorest improvements across all types of cancers. Despite the different rationales explored in targeted therapy for taming the GBM aggressiveness, its phenotypic plasticity, drug toxicity, and adaptive resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Doan, Phuong, Nguyen, Phung, Murugesan, Akshaya, Subramanian, Kumar, Konda Mani, Saravanan, Kalimuthu, Vignesh, Abraham, Bobin George, Stringer, Brett W., Balamuthu, Kadalmani, Yli-Harja, Olli, Kandhavelu, Meenakshisundaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345100/
https://www.ncbi.nlm.nih.gov/pubmed/34359676
http://dx.doi.org/10.3390/cancers13153773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345100/
https://www.ncbi.nlm.nih.gov/pubmed/34359676
http://dx.doi.org/10.3390/cancers13153773

Ejemplares similares